Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis

Osteoporosis International

Volumn 14, Issue 5, 2003, Pages 442-449

  Brown, S A ^a   Ontjes, D A ^a   Lester, G E ^a   Lark, R K ^a   Hensler, M B ^a   Blackwood, A D ^a   Caminiti, M J ^a   Backlund, D C ^a   Aris, R M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bone turnover markers; Calcitriol; Calcium; Cystic fibrosis; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CALCIUM 45; CALCIUM ION; CREATININE; PARATHYROID HORMONE;

ADULT; AGE; ARTICLE; BODY MASS; BONE MINERALIZATION; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM BALANCE; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; VITAMIN D DEFICIENCY;

ADMINISTRATION, ORAL; ADULT; AGED; BONE REMODELING; CALCITRIOL; CALCIUM; COLLAGEN; COLLAGEN TYPE I; CYSTIC FIBROSIS; FEMALE; HOMEOSTASIS; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES; RISK FACTORS;

EID: 0042206357     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-002-1331-x     Document Type: Article

References (42)

1. Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998;128:186-93.
2. Ott SM, Aitken ML. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998;19:555-67.
3. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999;54:961-7.
4. Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr 1996;128:28-34.
5. Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 1998;133:18-27.
6. Aris RM, Lester GE, Dingman S, Ontjes DA. Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int 1999;10:102-8.
7. Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 2002;13:151-7.
8. Lark RK, Lester GE, Ontjes DA, et al. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 2001;73:602-6.
9. 3 in the chylomicron fraction of plasma after oral administration in man. Clin Sci 1981;60:241-3.
10. Sitrin MD, Bengoa JM. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in chronic cholestatic liver disease. Am J Clin Nutr 1987;46:1011-5.
11. Maislos M, Silver J, Fainaru M. Intestinal absorption of vitamin D sterols: differential absorption into lymph and portal blood in the rat. Gastroenterology 1981;80:1528-34.
12. Davies M, Mawer EB, Klass JH, Lumb GA, Berry JL, Warnes TW. Vitamin D deficiency, osteomalacia and primary biliary cirrhosis. Dig Dis Sci 1983;28:145-52.
13. van den Berg H. Bioavailability of vitamin D. Eur J Clin Nutr 1997;51(Suppl 1):S76-9.
14. Marshall DH, Nordin BEC. A comparison of radioactive absorption tests with net calcium absorption. Clin Sci 1981;61:477-81.
15. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-61.
16. Francis RM, Peacock M. Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr 1987;46:315-8.
17. Favus M. Intestinal calcium absorption: have we absorbed enough from research to have a test for the patient? J Bone Miner Res 1989:4;461-2.
18. Kinyamu HK, Gallagher JC, Prahl JM, Deluca HF, Petranick KM, Lanspa SJ. Association between intestinal vitamin D receptor, calcium absorption and serum 1,25-vitamin D in normal young and elderly women. J Bone Miner Res 1997;12:922-8.
19. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Hollick MF. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 1997;82:4111-6.
20. Dijkgraaf-Ten Bolscher M, Netelenbos JC, Barto R, van Der Vijgh WJ. Strontium as a marker for intestinal calcium absorption: the stimulatory effect of calcitriol. Clin Chem 2000;46:248-51.
21. 2D3 bolus in normal subjects. J Bone Miner Res 1999;14:1789-95.
22. Dawson-Hughes B, Harris SS, Finneran S, Rasmussen HM. Calcium absorption responses to calcitriol in black and white premenopausal women. J Clin Endocrinol Metab 1995;80:3068-72.
23. 3 on intestinal absorption of calcium in normal man and patients with renal failure. Metabolism 1978;27:745-53.
24. 3 in man. J Clin Invest 1976;57:1540-7.
25. Heaney RP, Recker RR. Estimation of true calcium absorption. Ann Intern Med 1985;103:516-21.
26. Hanly JG, McKenna MJ, Quigley C, Freaney R, Muldowney FP, Fitzgerald MX. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 1985;56:377-85.
27. Ontjes DA, Lark RK, Lester GE, Hollis BW, Hensler MM, Aris RM. Vitamin D depletion and replacement in patients with cystic fibrosis. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D endocrine system: structural, biological, genetic and clinical aspects. Riverside, CA: University of California, Printing and Reprographics, 2000:893-6.
28. Tilyard MW, Spears GF, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-62.
29. 3, in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur J Clin Invest 1981;11:305-9.
30. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 1988;84:401-8.
31. Ott SM, Chestnut CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267-74.
32. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomized controlled study. Ann Intern Med 113:649-655.
33. Falch JA, Ogdegaard OR, Finnanager AM, et al. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecaciferol. Acta Med Scand 1987;221:199-204.
34. 3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabolism 1990;39(Suppl1):30-4.
35. Sairanen S, Karkkainen M, Tahtela, R, Laitinen K, Makela P, Lamberg-Allardt C, Valimaki MJ. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (calcitriol) for four years. Calcif Tissue Int 2000;67:122-7.
36. Kanis JA, McCloskey V, de Takats D, Bernard J, Zhang ZM. Treatment of osteoporosis with vitamin D. Osteoporos Int 1997;7(Suppl 3):S140-6.
37. Gallagher JC. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis. Metabolism 1990;39:27-9.
38. Gallagher JC, Fowler SE, Detter JR, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 2001;86:3618-28.
39. Ebeling PE, Wark JD, Yeung S, Poon C, Salehi N, Nicholson GC, Kotowicz MA. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 2001;86:4098-103.
40. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Resp Care 2000;162:941-6.
41. Haworth CS, Selby PL, Adams JE, Mawer EB, Horrocks AW, Webb AK. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001;56:314-6.
42. Haworth CS, Selby PL, Webb AK, Mawer EB, Adams JE, Fremont TJ. Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis. Lancet 1998;352:1753-4.